(EMAILWIRE.COM, December 24, 2018 ) According to the new market research report “In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) — Global Forecast to 2022”, published by MarketsandMarkets™.

Don’t miss out on business opportunities in In Vivo Toxicology Market.

The key factors driving the growth of this market include increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests.

The consumables segment is expected to hold the largest share of the market

Based on product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models. In 2017, the consumables segment is expected to account for the largest share of the in vivo toxicology market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis.

Browse and in-depth TOC on “In Vivo Toxicology Market”

124 — Tables

38 — Figures

196 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/in-vivo-toxicology-testing-market-105308811.html

By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period

The in vivo toxicology market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing. In 2017, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.

Request for Free Sample Report @

https://www.marketsandmarkets.com/pdfdownload.asp?id=105308811

The US is expected to dominate the in vivo toxicology market in 2017

In 2017, the US is estimated to account for the largest share of the in vivo toxicology market, followed by Germany and the UK. However, China is expected to grow at the highest CAGR during the forecast period. Factors such as rising R&D funding and collaborations; initiatives by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of the in vivo toxicology market in China.

The major players in the global in vivo toxicology market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).